| Mechanosensitive channel MSL8 regulates osmotic forces during pollen hydration and germination ES Hamilton, GS Jensen, G Maksaev, A Katims, AM Sherp, ES Haswell Science 350 (6259), 438-441, 2015 | 203 | 2015 |
| Risk factors for intravesical recurrence after minimally invasive nephroureterectomy for upper tract urothelial cancer (robuust collaboration) AB Katims, R Say, I Derweesh, R Uzzo, A Minervini, Z Wu, F Abdollah, ... The Journal of urology 206 (3), 568-576, 2021 | 38 | 2021 |
| Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions JL Pfail, AB Katims, P Alerasool, JP Sfakianos World Journal of Urology 39, 1319-1329, 2021 | 38 | 2021 |
| Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable AB Katims, S Razdan, BM Eilender, P Wiklund, AK Tewari, N Kyprianou, ... Urologic Oncology: Seminars and Original Investigations 38 (10), 783-792, 2020 | 27 | 2020 |
| Outcomes of lymph node dissection in nephroureterectomy in the treatment of upper tract urothelial carcinoma: analysis of the ROBUUST registry K Hakimi, U Carbonara, H Djaladat, R Mehrazin, D Eun, A Reese, ... The Journal of urology 208 (2), 268-276, 2022 | 17 | 2022 |
| Implementation of a nonopioid protocol following robot-assisted radical cystectomy with intracorporeal urinary diversion JL Pfail, EB Garden, Z Gul, AB Katims, SJ Rosenzweig, S Razdan, ... Urologic Oncology: Seminars and Original Investigations 39 (7), 436. e9-436. e16, 2021 | 14 | 2021 |
| Reclassification rates of patients eligible for active surveillance after the addition of magnetic resonance imaging-ultrasound fusion biopsy: an analysis of 7 widely used … B Nahar, A Katims, MP Barboza, NS Prakash, V Venkatramani, B Kava, ... Urology 110, 134-139, 2017 | 11 | 2017 |
| Bladder cancer carcinogens: opportunities for risk reduction CD Gaffney, A Katims, N D'Souza, MA Bjurlin, RS Matulewicz European Urology Focus, 2023 | 10 | 2023 |
| Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution … JL Pfail, AB Katims, Z Gul, SJ Rosenzweig, S Razdan, S Nathaniel, ... Urologic Oncology: Seminars and Original Investigations 39 (4), 233. e1-233. e8, 2021 | 10 | 2021 |
| Targeted therapies in advanced and metastatic urothelial carcinoma AB Katims, PA Reisz, L Nogueira, H Truong, AT Lenis, EJ Pietzak, K Kim, ... Cancers 14 (21), 5431, 2022 | 9 | 2022 |
| Radiogenomics in clear cell renal cell carcinoma: A review of the current status and future directions S Khaleel, A Katims, S Cumarasamy, S Rosenzweig, K Attalla, AA Hakimi, ... Cancers 14 (9), 2085, 2022 | 8 | 2022 |
| Robotic assisted radical cystectomy versus open radical cystectomy: a review of what we do and don’t know ZG Gul, AB Katims, JS Winoker, P Wiklund, N Waingankar, R Mehrazin Translational Andrology and Urology 10 (5), 2209, 2021 | 8 | 2021 |
| Tips and tricks in achieving zero peri-operative opioid used in onco-urologic surgery AB Katims, BM Eilender, JL Pfail, AJ Sim, JP Sfakianos World Journal of Urology, 1-8, 2020 | 7 | 2020 |
| The Evolving clinical management of genitourinary cancers amid the COVID-19 pandemic S Izadmehr, DJ Lundon, N Mohamed, A Katims, V Patel, B Eilender, ... Frontiers in Oncology 11, 734963, 2021 | 6 | 2021 |
| Long-term outcomes of laser incision and triamcinolone injection for the management of ureteroenteric anastomotic strictures AB Katims, BT Edelblute, AW Tam, AM Zampini, R Mehrazin, M Gupta Journal of Endourology 35 (1), 21-24, 2021 | 5 | 2021 |
| Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients AB Katims, AW Tam, DC Rosen, AM Zampini, W Atallah, R Mehrazin, ... Urologic Oncology: Seminars and Original Investigations 39 (4), 234. e9-234. e13, 2021 | 3 | 2021 |
| PD36-08 PERIOPERATIVE OUTCOMES OF RADICAL CYSTECTOMY FOLLOWING NEOADJUVANT GEMCITABINE, CISPLATIN AND ATEZOLIZUMAB A Mouzannar, K Whiting, I Ostrovnaya, A Katims, T Durdin, Z Feuer, ... The Journal of Urology 209 (Supplement 4), e983, 2023 | 2 | 2023 |
| Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc) RNA-sequencing (seq). AB Katims, F Kuo, P Reisz, A Tracey, J Thomas, W Yip, T Merghoub, ... Journal of Clinical Oncology 41 (6_suppl), 558-558, 2023 | 2 | 2023 |
| Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy AP Kenigsberg, G Carpinito, SA Gold, X Meng, A Ghoreifi, H Djaladat, ... Urologic Oncology: Seminars and Original Investigations 40 (10), 452. e17 …, 2022 | 2 | 2022 |
| The effect of tumor location on overall survival for pT2–4 bladder and upper tract urothelial carcinoma following radical surgery AW Tam, C Liaw, E Li, AB Katims, RK Say, Z Gul, JS Winoker, A Martini, ... Canadian Urological Association Journal 15 (5), E248, 2021 | 2 | 2021 |
